Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
672
-
Total 13F shares, excl. options
-
168M
-
Shares change
-
-5.22M
-
Total reported value, excl. options
-
$17.6B
-
Value change
-
-$523M
-
Put/Call ratio
-
1.36
-
Number of buys
-
387
-
Number of sells
-
-229
-
Price
-
$104.47
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q4 2020
808 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q4 2020.
Moderna, Inc. - COMMON STOCK (MRNA) has 672 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 168M shares
of 385M outstanding shares and own 43.72% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (24.3M shares), VANGUARD GROUP INC (23.4M shares), BlackRock Inc. (20.5M shares), FMR LLC (7.95M shares), STATE STREET CORP (6.02M shares), MORGAN STANLEY (5.8M shares), Theleme Partners LLP (5.34M shares), GEODE CAPITAL MANAGEMENT, LLC (3.57M shares), D. E. Shaw & Co., Inc. (3.11M shares), and BANQUE PICTET & CIE SA (3.02M shares).
This table shows the top 672 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.